Hospital outbreak of vancomycin-resistant enterococci caused by a single clone of Enterococcus raffinosus and several clones of Enterococcus faecium

Clinical Microbiology and Infection

Volumn 13, Issue 9, 2007, Pages 893-901

  Kawalec, Madziak ^a   Kedzierska J ^b   Gajda, A ^c   Sadowy, E ^a   Wegrzyn J ^d   Naser, S ^e   Skotnicki, A B ^d   Gniadkowski, M ^a   Hryniewicz, W ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^c UNIVERSITY OF WROC AW   (Poland)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

Enterococcus raffinosus; Identification; Outbreak; Tn1546 like element; VRE

Indexed keywords

AMPICILLIN; BACTERIAL PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; PENICILLIN G; PROTEIN VANA; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDEMIC SPECIES; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS RAFFINOSUS; GENE ISOLATION; GENE LOCATION; GENE LOCUS; GENE STRUCTURE; GENETIC ANALYSIS; HOSPITAL INFECTION; HUMAN; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLAND; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ENTEROCOCCUS AVIUM; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS RAFFINOSUS;

EID: 34547827981     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01774.x     Document Type: Article

References (38)

1. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003; 51 (suppl 3): 13-21.
2. Goossens H, Jabes D, Rossi R, Lammens C, Privitera G, Courvalin P. European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates. J Antimicrob Chemother 2003; 51 (suppl 3): 5-12.
3. Timmers GJ, van der Zwet WC, Simoons-Smit IM et al. Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: Risk factor assessment and successful control of the epidemic. Br J Haematol 2002; 116: 826-833.
4. Murray BE. Vancomycin-resistant enterococci. Am J Med 1997; 102: 284-293.
5. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000; 13: 686-707.
6. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother 1993; 37: 2311-2317.
7. Jones RN, Marshall SA, Pfaller MA et al. Nosocomial enterococcal blood stream infections in the SCOPE Program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis 1997; 29: 95-102.
8. Johnson AP, Warner M, Hallas G, Livermore DM. Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999. J Antimicrob Chemother 2000; 46: 125-128.
9. Cooper RA, Molan PC, Harding KG. The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol 2002; 93: 857-863.
10. Togneri AM, Corso A, Gonzalez J et al. Clinical and epidemiologic analysis of intestinal tract colonization with vancomycin-resistant enterococci in an intensive care unit. Rev Argent Microbiol 2005; 37: 26-33.
11. Tanimoto K, Nomura T, Maruyama H et al. The first VanD-type vancomycin-resistant Enterococcus raffinosus. Antimicrob Agents Chemother 2006; 50: 3966-3967.
12. Wilke WW, Marshall SA, Coffman SL et al. Vancomycin-resistant Enterococcus raffinosus: Molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program. Diagn Microbiol Infect Dis 1997; 29: 43-49.
13. Kawalec M, Gniadkowski M, Hryniewicz W. Outbreak of vancomycin-resistant enterococci in a hospital in Gda Ńsk, Poland, due to horizontal transfer of different Tn1546-like transposon variants and clonal spread of several strains. J Clin Microbiol 2000; 38: 3317-3322.
14. Kawalec M, Gniadkowski M, Kedzierska J, Skotnicki A, Fiett J, Hryniewicz W. Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the VanB phenotype. J Clin Microbiol 2001; 39: 4274-4282.
15. Kawalec M, Gniadkowski M, Zaleska M, Ozorowski T, Konopka L, Hryniewicz W. Outbreak of vancomycin-resistant Enterococcus faecium of the phenotype VanB in a hospital in Warsaw, Poland: Probable transmission of the resistance determinants into an endemic vancomycin-susceptible strain. J Clin Microbiol 2001; 39: 1781-1787.
16. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989; 27: 731-734.
17. Naser SM, Thompson FL, Hoste B et al. Application of multilocus sequence analysis (MLSA) for rapid identification of Enterococcus species based on rpoA and pheS genes. Microbiology 2005; 151: 2141-2150.
18. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn 1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993; 175: 117-127.
19. Leclercq R, Dutka-Malen S, Duval J, Courvalin P. Vancomycin resistance gene vanC is specific to Enterococcus gallinarum. Antimicrob Agents Chemother 1992; 36: 2005-2008.
20. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 16th informational supplement, M100-S16. Wayne, PA: CLSI, 2006.
21. Werner G, Klare I, Witte W. Arrangement of the vanA gene cluster in enterococci of different ecological origin. FEMS Microbiol Lett 1997; 155: 55-61.
22. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
23. Palepou MF, Adebiyi AM, Tremlett CH, Jensen LB, Woodford N. Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci. J Antimicrob Chemother 1998; 42: 605-612.
24. Grayson ML, Eliopoulos GM, Wennersten CB et al. Comparison of Enterococcus raffinosus with Enterococcus avium on the basis of penicillin susceptibility, penicillin-binding protein analysis, and high-level aminoglycoside resistance. Antimicrob Agents Chemother 1991; 35: 1408-1412.
25. Handwerger S, Skoble J, Discotto LF, Pucci MJ. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States. Antimicrob Agents Chemother 1995; 39: 362-368.
26. Simonsen GS, Myhre MR, Dahl KH, Olsvik O, Sundsfjord A. Typeability of Tn1546-like elements in vancomycin-resistant enterococci using long-range PCRs and specific analysis of polymorphic regions. Microb Drug Resist 2000; 6: 49-57.
27. Camargo IL, Del Peloso PF, Da Costa Leite CF, Goldman GH, Darini AL. Identification of an unusual VanA element in glycopeptide-resistant Enterococcus faecium in Brazil following international transfer of a bone marrow transplant patient. Can J Microbiol 2004; 50: 767-770.
28. Pearce CL, Evans MK, Peters SM, Cole MF. Clonal diversity of vancomycin-resistant enterococci from an outbreak in a tertiary care university hospital. Am J Infect Control 1998; 26: 563-568.
29. Patel R, Keating MR, Cockerill FR, Steckelberg JM. Bacteremia due to Enterococcus avium. Clin Infect Dis 1993; 17: 1006-1011.
30. Watanakunakorn C, Patel R. Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin. Clin Infect Dis 1993; 17: 74-78.
31. Rosato A, Pierre J, Billot-Klein D, Buu-Hoi A, Gutmann L. Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium. Antimicrob Agents Chemother 1995; 39: 830-833.
32. Hsieh SR. Antimicrobial susceptibility and species identification for clinical isolates of enterococci. J Microbiol Immunol Infect 2000; 33: 253-257.
33. von Gottberg A, van Nierop W, Duse A et al. Epidemiology of glycopeptide-resistant enterococci colonizing high-risk patients in hospitals in Johannesburg, Republic of South Africa. J Clin Microbiol 2000; 38: 905-909.
34. Willems RJ, Top J, van den Braak N et al. Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob Agents Chemother 1999; 43: 483-491.
35. Woodford N, Adebiyi AM, Palepou MF, Cookson BD. Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. Antimicrob Agents Chemother 1998; 42: 502-508.
36. Brown AR, Townsley AC, Amyes SG. Diversity of Tn 1546 elements in clinical isolates of glycopeptide-resistant enterococci from Scottish hospitals. Antimicrob Agents Chemother 2001; 45: 1309-1311.
37. Schouten MA, Willems RJ, Kraak WA, Top J, Hoogkamp-Korstanje JA, Voss A. Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering. Antimicrob Agents Chemother 2001; 45: 986-989.
38. Mundy LM, Sahm DF, Gilmore M. Relationships between enterococcal virulence and antimicrobial resistance. Clin Microbiol Rev 2000; 13: 513-522.